Positron emission tomography in lung cancer

https://doi.org/10.1053/snuc.2002.126059Get rights and content

Carcinoma of the lung is one of the most frequent malignancies and a major cause of mortality. The use of positron emission tomography (PET) has been extensively investigated in patients with carcinoma of the lung and has established clinical utility and cost-effectiveness in characterization of solitary pulmonary nodules and preoperative staging of carcinoma of the lung. Evolving applications in carcinoma of the lung include detection of recurrence, assessment of treatment response, radiotherapy planning, and prognosis. In addition, there is developing interest in combined anatomic/metabolic imaging and new tracer techniques, in particular gene expression imaging. This review aims to present existing data supporting the use of PET in carcinoma of the lung and to explore the evolving indications and future prospects of PET and lung cancer.

References (298)

  • ViggianoRW et al.

    Evaluation and management of solitary and multiple pulmonary nodules

    Clin Chest Med

    (1992)
  • SwansonSJ et al.

    Management of the solitary pulmonary nodule: Role of thoracoscopy in diagnosis and therapy

    Chest

    (1999)
  • KhouriNF et al.

    The solitary pulmonary nodule. Assessment, diagnosis, and management

    Chest

    (1987)
  • ShafferK

    Role of radiology for imaging and biopsy of solitary pulmonary nodules

    Chest

    (1999)
  • KauczorHU et al.

    Contrast-enhanced MRI of the lung

    Eur J Radiol

    (2000)
  • ChechaniV

    Bronchoscopic diagnosis of solitary pulmonary nodules and lung masses in the absence of endobronchial abnormality

    Chest

    (1996)
  • NaidichDP et al.

    Solitary pulmonary nodules. CT-bronchoscopic correlation

    Chest

    (1988)
  • WallaceJM et al.

    Flexible fiberoptic bronchoscopy and percutaneous needle lung aspiration for evaluating the solitary pulmonary nodule

    Chest

    (1982)
  • CorteseDA et al.

    Biopsy and brushing of peripheral lung cancer with fluoroscopic guidance

    Chest

    (1979)
  • YankelevitzDF et al.

    CT-guided transthoracic needle biopsy following indeterminate fiberoptic bronchoscopy in solitary pulmonary nodules

    Clin Imaging

    (1998)
  • LevineMS et al.

    Transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in solitary pulmonary nodules

    Chest

    (1988)
  • CalhounP et al.

    The clinical outcome of needle aspirations of the lung when cancer is not diagnosed

    Ann Thorac Surg

    (1986)
  • DewanNA et al.

    PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

    Chest

    (1995)
  • LarscheidRC et al.

    Percutaneous transthoracic needle aspiration biopsy: A comprehensive review of its current role in the diagnosis and treatment of lung tumors

    Chest

    (1998)
  • MitrukaS et al.

    Diagnosing the indeterminate pulmonary nodule: Percutaneous biopsy versus thoracoscopy

    Surgery

    (1995)
  • AllenMS et al.

    Video-assisted thoracoscopic stapled wedge excision for indeterminate pulmonary nodules

    J Thorac Cardiovasc Surg

    (1993)
  • KnightSB et al.

    Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

    Chest

    (1996)
  • QuinnMJ et al.
  • RiesL et al.

    SEER Cancer Statistics Review

    (1973)
  • GinsbergR et al.

    Non-small cell lung cancer

  • MurrenJ et al.

    Small cell lung cancer

  • ChitiA et al.

    Nuclear medicine procedures in lung cancer

    Eur J Nucl Med

    (1999)
  • Abdel-DayemHM et al.

    Tracer imaging in lung cancer

    Eur J Nucl Med

    (1994)
  • BuccheriG et al.

    Yield of total body Ga-67 scintigraphy in the staging of non-small cell lung cancer

    Tumori

    (1989)
  • KashitaniN et al.

    Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma

    Oncol Rep

    (1999)
  • IkedaE et al.

    Thallium-201 SPECT with triple-headed gamma camera for differential diagnosis of small pulmonary nodular lesion 20 mm in diameter or smaller

    Ann Nucl Med

    (2000)
  • IshibashiM et al.

    Relationship between cancer cell proliferation and thallium-201 uptake in lung cancer

    Ann Nucl Med

    (2000)
  • TakekawaH et al.

    Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma

    Cancer

    (1997)
  • SugaK et al.

    201T1 SPECT as in indicator for early prediction of therapeutic effects in patients with non-small cell lung cancer

    Ann Nucl Med

    (1998)
  • HigashiK et al.

    Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer

    J Nucl Med

    (1998)
  • HigashiK et al.

    Comparison of [(18)F]FDG PET and (201)T1 SPECT in evaluation of pulmonary nodules

    J Nucl Med

    (2001)
  • YamamotoY et al.

    Comparative evaluation of Tc-99m MIBI and T1-201 chloride SPECT in non-small-cell lung cancer mediastinal lymph node metastases

    Clin Nucl Med

    (2000)
  • TonamiN et al.

    Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer

    J Nucl Med

    (1989)
  • HassanIM et al.

    Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs

    Clin Nucl Med

    (1989)
  • KaoCH et al.

    Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile

    Eur J Nucl Med

    (1993)
  • WangH et al.

    Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging

    Clin Nucl Med

    (1997)
  • TanakaS et al.

    Effectiveness of Tc-99m MIBI scintigraphy in diagnosing lung cancer

    Surg Today

    (1997)
  • MinaiOA et al.

    Role of Tc-99m MIBI in the evaluation of single pulmonary nodules: A preliminary report

    Thorax

    (2000)
  • ShiauYC et al.

    Technetium-99m methoxyisobutyl-isonitrile chest single photon emission computed tomography to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer: Comparison with computed tomography

    Anticancer Res

    (2000)
  • KostakogluL et al.

    Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer

    J Nucl Med

    (1998)
  • Cited by (57)

    • <sup>18</sup>F-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease

      2018, PET Clinics
      Citation Excerpt :

      Therefore, a simple view of the metabolic degree of the lesions is not enough, and it is therefore very important that the morphology of the lesion with high radioactivity uptake on 18F-FDG PET imaging should also be taken into consideration. Numerous studies have reported on the use of 18F-FDG PET imaging in the diagnosis of SPN and lung tumor.42–44 Gould and colleagues45 in their meta-analysis found that for pulmonary lesions, the overall sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 18F-FDG PET imaging were approximately 96%, 78%, 91%, and 92%, respectively.

    • Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy

      2010, Seminars in Nuclear Medicine
      Citation Excerpt :

      Areas of increased uptake in the marrow, thymus, and lymphoid tissues reflects the degree of posttherapy stimulation within these sites. Increased FDG uptake may persist in surgical sites or irradiated tissue up to 6 months after conclusion of treatment.146 The tumor itself may exhibit transient decrease in uptake or increase in uptake (flare)147 because of therapy and not reflecting ultimate tumor status.

    • Positron Emission Tomography/Computed Tomography Potential Pitfalls and Artifacts

      2009, Current Problems in Diagnostic Radiology
      Citation Excerpt :

      Although 18F-FDG-PET imaging can detect occult relapse of colorectal cancer in 65% of patients with rising carcinoembryonic antigen (CEA) levels but no obvious site of tumor recurrence,43 it may not be able to differentiate postsurgical inflammation and tumor recurrence. FDG may be accumulated in irradiated tissues and postsurgical inflammatory changes up to 6 months after the end of treatment.44 PET/CT provides both functional and anatomic information in a single imaging study.

    • Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition)

      2007, Chest
      Citation Excerpt :

      In addition, uptake on PET scans has been reported in the pleura of the shielded, nonirradiated lung even in the absence of overt radiation pneumonitis.89 It has been recommended that PET scans for evaluating recurrent disease not be performed after curative intent therapy for at least 3 to 6 months to minimize the possibility of false-positive findings, and that suspicious lesions on a surveillance PET scan be confirmed by CT imaging and biopsy.82, 90 Importantly, there are no data showing that incorporating PET scanning into a surveillance program improves either survival or quality of life following curative intent therapy for NSCLC.

    View all citing articles on Scopus
    View full text